Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients. — Gianpietro Dotti (2001) | RDL Network
Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Article 2001 en
Authors
GD
Gianpietro Dotti
FG
Flavio Gaspari
RC
Raffaele Caruso
Abstract
1 min read
Our data suggest that oral administration of Neoral 7.5 mg/kg/day early after allo-BMT may represent an appropriate dose resulting in adequate CsA C(trough) levels without significant renal toxicity.
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.